Evoke Wealth’s Immunomedics Inc IMMU Stock Holding History

Evoke Wealth’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-517	Closed	-$6.86K	–	1537
2019 Q3	$6.86K	Buy	+517	New	+$7.6K	﹤0.01%	910

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Evoke Wealth's IMMU Position: Q4 2019 in Review

Evoke Wealth sold out of Immunomedics Inc (IMMU) in Q4 2019, closing a stake of 517 shares — an estimated $6.86K sold.

Evoke Wealth first reported a position in IMMU in Q3 2019 and held it in 1 quarter. The position peaked at $6.86K in Q3 2019. 245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

Evoke Wealth reported no remaining Immunomedics Inc position as of Q4 2019 after selling out during the quarter.
Evoke Wealth sold 517 Immunomedics Inc shares in Q4 2019, an estimated $6.86K.
Evoke Wealth first reported a position in Immunomedics Inc in Q3 2019 and held it in 1 quarter.
Evoke Wealth's Immunomedics Inc position peaked at $6.86K in Q3 2019.
245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.